Top Markets
Coin of the day
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Classificação em ações #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
Preço da ação
$0.1
Última sincronização: 2024-06-18
Valor de mercado
$1.31M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Pascal Biosciences Inc. (PSCBF)

Categoria

EPS de Pascal Biosciences Inc. (PSCBF)
EPS em February 2024 TTM: $-0.01
De acordo com os últimos relatórios financeiros e o preço das ações da Pascal Biosciences Inc., o EPS atual da empresa (TTM) é $-0.01. No final de 2022, a empresa teve um EPS de $-0.03, uma diminuição em relação a ao EPS de 2021, que foi de $-0.07.
Histórico de EPS da Pascal Biosciences Inc. de 2019 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $-0.01 -5.00%
2023 $-0.01 -54.55%
2022 $-0.03 -59.08%
2021 $-0.07 -21.22%
2020 $-0.09 -64.47%
2019 $-0.24 0.00%
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
$17.32 -182,415.79%
US
$27.74 -292,100.00%
NL
- -
CH
- -
KR
$13.70 -144,311.58%
BE